Pharmaceuticals
Eli Lilly wins against generics in Germany in pemetrexed dispute
Eli Lilly has achieved a ban on the sale of imitation pemetrexed products in Germany, in the ongoing dispute over its cancer drug Alimta. Following th
...
28 July 2020 by Konstanze Richter